V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryTech Transfer
Compliance · The complete guide

Tech TransferTechnology Transfer

In short

The systematic process of transferring process knowledge and manufacturing capability from a development or sending site to a receiving site while maintaining product quality.

2,370 words · ~11 min read
Two engineers reviewing documents beside a pilot-scale stainless steel reactor in a technology transfer suite
Technology transfer moves a process from development or one site into routine production at another, with evidence the receiving site can run it.
On this page
  1. 01The Critical Role of Technology Transfer in Life Sciences
  2. 02Regulatory Framework: ICH Q10 and Global Expectations
  3. 03Common Scenarios for Technology Transfer
  4. 04The Technology Transfer Plan: Defining the Roadmap
  5. 05Knowledge Management: The 'Soul' of the Transfer
  6. 06Establishing Comparability: Proving the Product is the Same
  7. 07Analytical Method Transfer (AMT)
  8. 08Risk Management: Identifying Transfer Pitfalls
  9. 09Validation at the Receiving Site: PPQ and Beyond
  10. 10The Technology Transfer Package (TTP): What’s Inside?
On this page · 10 sections
  1. 1The Critical Role of Technology Transfer in Life Sciences
  2. 2Regulatory Framework: ICH Q10 and Global Expectations
  3. 3Common Scenarios for Technology Transfer
  4. 4The Technology Transfer Plan: Defining the Roadmap
  5. 5Knowledge Management: The 'Soul' of the Transfer
  6. 6Establishing Comparability: Proving the Product is the Same
  7. 7Analytical Method Transfer (AMT)
  8. 8Risk Management: Identifying Transfer Pitfalls
  9. 9Validation at the Receiving Site: PPQ and Beyond
  10. 10The Technology Transfer Package (TTP): What’s Inside?
AI · Explain it for MY operation

How does Tech Transfer apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01The Critical Role of Technology Transfer in Life Sciences

Technology transfer, often abbreviated as tech transfer, is the multi-disciplinary process of moving a manufacturing process, analytical method, or product formulation from a 'Sending Unit' (SU)—such as an R&D lab or an existing manufacturing site—to a 'Receiving Unit' (RU). In the pharmaceutical and biotechnology sectors, tech transfer is not a single event but a complex sequence of knowledge sharing, risk assessment, and validation activities. It is the bridge that allows a discovery at the bench top to reach the bedside of a patient at scale.

The primary objective of technology transfer is to ensure that the RU can consistently produce a product that meets its predefined quality specifications, just as the SU did. This requires far more than handing over a recipe or a set of Standard Operating Procedures (SOPs). It involves the transfer of 'process understanding'—the underlying science of why a process works, how it responds to variability, and where its critical limits lie. Without a robust transfer process, manufacturers risk batch failures, regulatory delays, and significant financial loss.

Modern manufacturing environments are increasingly globalized, meaning a process developed in a high-tech facility in Europe might need to be transferred to a contract manufacturing organization (CMO) in Asia. In these scenarios, the transfer must account for differences in equipment, facility design, environmental conditions, and even the cultural nuances of operator training. The goal is to achieve 'equivalence' or 'comparability' between the two sites, ensuring that the patient receives the same therapeutic benefit regardless of where the drug was made.

Technology transfer is a 'lifecycle' activity. It doesn't just happen once at launch; it occurs whenever a process is moved, scaled up, or optimized by a different team or facility.

02Regulatory Framework: ICH Q10 and Global Expectations

Regulatory bodies like the FDA and EMA view technology transfer as a central component of a modern Pharmaceutical Quality System (PQS). The most authoritative guidance on the subject is ICH Q10: Pharmaceutical Quality System, which identifies technology transfer as one of the four key stages of the product lifecycle. According to ICH Q10, the goal of technology transfer is to 'transfer product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve product realization.' 1

ICH Q10 emphasizes that the transfer process should be underpinned by two enablers: Knowledge Management and Quality Risk Management. Knowledge management ensures that the insights gained during the development phase are not lost when the project moves to commercial production. Quality risk management provides the framework for identifying what could go wrong during the transfer and focusing resources on the most critical parameters.

The FDA's 2011 Guidance on Process Validation also reinforces the importance of tech transfer, particularly in Stage 1 (Process Design). The guidance suggests that the knowledge gained during this stage is the foundation for the entire validation lifecycle. If the transfer of this knowledge is incomplete, the manufacturer will struggle to demonstrate that they are in a 'state of control' during Stage 2 (Process Qualification) and Stage 3 (Continued Process Verification).

Global Harmonization and EU Annex 15

In the European Union, EudraLex Volume 4, Annex 15 (Qualification and Validation) provides specific requirements for technology transfer. It mandates that a transfer should be described in a written plan and that the Receiving Unit should demonstrate that the process can be performed successfully. It also highlights the need for a 'gap analysis' to identify differences in equipment and facilities between the SU and RU, which must be addressed before the transfer is considered complete.

03Common Scenarios for Technology Transfer

Technology transfer occurs in various contexts throughout a product's life. Understanding the specific scenario helps in tailoring the transfer plan to the appropriate level of risk and detail.

  • Development to Commercial: The move from R&D or clinical trial manufacturing to full-scale commercial production. This is often the most difficult transfer because it involves a significant scale-up (e.g., from a 50-liter pilot batch to a 2,000-liter commercial batch) and a shift from a flexible lab environment to a rigid GMP environment.
  • Site-to-Site (Internal): Moving a process between two facilities owned by the same company. While equipment and quality systems might be similar, differences in local environmental factors (humidity, water quality) and personnel experience still necessitate a formal transfer.
  • In-sourcing/Out-sourcing: Transferring a process to a Contract Development and Manufacturing Organization (CDMO) or bringing a process back in-house. These transfers require intense scrutiny of the contractual quality agreements and the alignment of two different quality systems.
  • Scale-up/Scale-down: Adjusting the batch size within the same facility. While not a move between different units, this is still treated as a tech transfer because it often requires changes to equipment settings and process parameters.

Regardless of the scenario, the 'sending' and 'receiving' roles must be clearly defined. The Sending Unit is the expert on the process; the Receiving Unit is the expert on the facility where the process will run. Success depends on the friction-less collaboration of these two parties.

04The Technology Transfer Plan: Defining the Roadmap

A successful transfer starts with a comprehensive Technology Transfer Plan (TTP). This document serves as the project charter, aligning all stakeholders on the scope, objectives, and success criteria. A TTP should be treated as a live document, updated as new risks are identified or as data is generated during the transfer process.

Key components of a robust transfer plan include:

  1. Project Scope: Exactly which products, processes, and analytical methods are being transferred.
  2. Roles and Responsibilities: A RACI matrix (Responsible, Accountable, Consulted, Informed) for both the SU and RU teams.
  3. Resource Requirements: Specialized equipment, raw material quantities, and personnel time.
  4. Timeline and Milestones: Key stages like the transfer of the documentation package, training, feasibility batches, and finally, the PPQ batches.
  5. Acceptance Criteria: The statistical and quality benchmarks that must be met to declare the transfer a success. This usually includes comparability of CQAs (Critical Quality Attributes).
  6. Gap Analysis: A detailed comparison of the equipment and facility capabilities at both sites.

V5 helps teams digitize this roadmap. Instead of managing the transfer via disparate spreadsheets and emails, the system provides a centralized repository for the transfer package, allowing both the SU and RU to track tasks, share documents, and monitor real-time data from feasibility runs.

05Knowledge Management: The 'Soul' of the Transfer

One of the most common reasons for failed technology transfers is the failure to transfer 'tacit knowledge.' Tacit knowledge is the unwritten, experience-based insight that operators and scientists gain through years of working with a process. Examples include 'knowing the exact sound a pump makes when it's about to cavitate' or 'knowing the subtle color change that indicates a reaction is nearing completion.'

To capture this, the transfer process must move beyond explicit knowledge (SOPs, Master Batch Records, and specifications) and include:

  • Face-to-Face Training: Sending operators from the RU to the SU to observe and participate in runs.
  • On-site Support: Having SU scientists present at the RU during the first few feasibility and validation batches.
  • Development Reports: Sharing the history of 'failed' experiments or 'out-of-specification' results during development, so the RU knows what boundaries not to push.
  • Video Documentation: Recording complex manual steps to ensure the RU can replicate the exact movements required.

ICH Q10 defines knowledge management as a systematic approach to acquiring, analyzing, storing, and disseminating information. In tech transfer, this means creating a 'Process Description' document that explains the 'why' behind every Critical Process Parameter (CPP), not just the 'what.' 1

06Establishing Comparability: Proving the Product is the Same

The core challenge of tech transfer is proving that the product manufactured at the Receiving Unit is 'comparable' to the product manufactured at the Sending Unit. Comparability does not mean the products are identical in every physical way, but rather that they have the same quality, safety, and efficacy profiles.

Comparability is typically established through a combination of:

1. Analytical Testing

Extensive side-by-side testing of samples from both sites. This often goes beyond standard release testing to include characterization studies (e.g., forced degradation, impurity profiling, and protein folding analysis for biologics).

2. Statistical Evaluation

Using tools like Equivalence Testing or T-tests to determine if the differences in data between sites are statistically significant or merely due to natural variation. Manufacturers often use 'tolerance intervals' or 'prediction intervals' from the SU data to set the acceptance criteria for the RU.

3. Stability Studies

Placing batches from the new site on stability to ensure that the shelf-life profile has not been negatively impacted by the move.

If the process involves significant changes (e.g., changing the manufacturing equipment from one vendor to another), the regulatory burden for proving comparability increases. In some cases, particularly for complex biologics, the FDA may require clinical bridging studies if analytical comparability cannot be fully demonstrated.

07Analytical Method Transfer (AMT)

A manufacturing process cannot be validated if the methods used to test the product are not reliable. Analytical Method Transfer is the process of proving that the RU laboratory can perform the test methods (HPLC, GC, dissolution, etc.) with the same accuracy and precision as the SU laboratory.

There are four main types of AMT recognized by industry (e.g., USP <1224>):

  • Comparative Testing: The SU and RU laboratories test the same samples and compare their results against predefined acceptance criteria.
  • Co-validation: The RU laboratory participates in the original validation study for the method, effectively becoming a 'validated' lab from the start.
  • Re-validation: The RU laboratory performs a full or partial validation of the method on-site.
  • Transfer Waiver: In rare cases (e.g., if the RU lab is already using the method for another product), the transfer can be waived with a documented justification.

A common pitfall in AMT is ignoring the differences in lab equipment. For example, two HPLCs from different manufacturers may have different 'dwell volumes,' which can lead to shifts in retention times for complex gradients. The transfer protocol must account for these variations.

08Risk Management: Identifying Transfer Pitfalls

Technology transfer is fraught with risk. Quality Risk Management (QRM), as outlined in ICH Q9, should be used throughout the process to identify and mitigate these risks. A Failure Mode and Effects Analysis (FMEA) is often conducted before the transfer begins.

Common risks identified during tech transfer include:

  • Raw Material Variability: The RU might use a different supplier for an excipient, leading to unexpected changes in the final product's physical properties.
  • Environmental Sensitivity: A process that is stable in a low-humidity environment in Switzerland might fail in a tropical environment if the facility's HVAC system is not robust.
  • Equipment Non-Equivalence: Differences in heat transfer coefficients in bioreactors or different shear rates in mixers can significantly alter product yield and quality.
  • Documentation Gaps: Incomplete development records that fail to mention the 'design space'—the ranges within which process parameters can safely vary.

By identifying these risks early, the transfer team can design 'engineering runs' or 'feasibility studies' to test the most vulnerable parts of the process before committing to expensive validation batches.

09Validation at the Receiving Site: PPQ and Beyond

Once the RU has successfully completed its feasibility runs and established comparability, it must enter the formal validation phase. In the FDA's lifecycle model, this is Stage 2: Process Qualification (PQ or PPQ). The RU must demonstrate that the process, now running in a new facility with new operators and equipment, can consistently produce a product that meets specifications.

The Process Performance Qualification (PPQ) protocol for the new site should be based on the knowledge transferred from the SU. It typically involves at least three consecutive successful batches, although modern guidance suggests that the number of batches should be justified based on risk and process understanding rather than a 'rule of three.'

Successful PPQ marks the end of the 'transfer' phase and the beginning of the 'commercial' phase. However, the connection to the SU should not be severed immediately. The SU often provides 'post-transfer support' for a period of six months to a year to help troubleshoot any issues that arise during early commercial production.

The tech transfer is only truly complete when the Receiving Unit can operate the process independently and the data from Continued Process Verification (Stage 3) shows the process is stable and capable.

10The Technology Transfer Package (TTP): What’s Inside?

The TTP is the definitive collection of all knowledge and documentation required for the transfer. An honest, high-quality TTP should include the following:

CategoryKey Deliverables
Product KnowledgeProduct Profile (QTPP), CQAs, Formulation details, Stability data.
Process KnowledgeProcess Flow Diagrams, CPPs, Design Space (if applicable), History of failures/deviations.
Analytical MethodsTest protocols, Validation reports, Reference standards, AMT protocols.
EquipmentEquipment specifications, User Requirement Specifications (URS), Maintenance history.
RegulatoryCopies of filing dossiers (IND/NDA/BLA), Correspondence with health authorities.
Supply ChainApproved vendor list for raw materials, Material Safety Data Sheets (MSDS).

A 'lean' TTP that lacks these details will inevitably lead to delays. The quality of the transfer is directly proportional to the quality of the TTP.

Frequently asked questions

Q.What is the difference between tech transfer and process validation?+

Technology transfer is the process of moving the knowledge and capability from one site to another. Process validation (specifically Stage 2 PPQ) is the formal evidence that the process works as intended at the new site. Tech transfer is the prerequisite; validation is the proof.

Q.How many batches are required for a successful technology transfer?+

There is no fixed regulatory number. While 'three consecutive batches' was the historical norm for PPQ, modern guidance (FDA 2011) emphasizes a risk-based approach. The number of batches should be sufficient to demonstrate statistical confidence that the process is in control at the new site.

Q.What is a 'Sending Unit' (SU) and a 'Receiving Unit' (RU)?+

The Sending Unit is the facility or group that currently owns the process and knowledge (e.g., R&D or a commercial site). The Receiving Unit is the facility that will be taking over the manufacturing of the product. Successful transfer requires a formal partnership between both.

Q.Can a technology transfer be performed without analytical method transfer?+

It is highly discouraged. Unless the RU is already validated to perform the exact same methods using the same equipment types, a formal AMT is required to ensure the data generated during manufacturing validation is accurate.

Primary sources

  • ICH Q10: Pharmaceutical Quality System
  • FDA Guidance for Industry: Process Validation (2011)
  • ISPE Good Practice Guide: Technology Transfer
  • EU GMP Annex 15: Qualification and Validation

Further reading

  • Process Validation
    Understand the three-stage lifecycle approach that frames all modern technology transfer activities.
  • Process Performance Qualification (PPQ)
    The critical final step in a tech transfer where the receiving site proves its capability.
  • Continued Process Verification (CPV)
    Monitoring the process after the transfer to ensure long-term stability and quality.
  • Change Control
    How to manage the regulatory and quality impacts of moving a process between sites.

Explore this topic

Tech Transfer sits inside 2 overlapping topic clusters in our glossary. Every neighbour is one click away.

Pharmaceutical GMP
25 related entries

Drug-product cGMP rules, ICH Q-series, and the regulators that enforce them.

21 CFR 21021 CFR 21121 CFR 21221 CFR 58ICH Q7ICH Q9ICH Q10ICH Q2ICH Q6GxPQP ReleaseConditional ReleaseDeviationOOSOOTCAPANCRLine ClearanceCPVAPIExcipientUSPOEL / OEBCMO / CDMO ManagementCell & Gene Therapy Manufacturing
QbD, Design Space & Lifecycle
13 related entries

ICH Q8/Q11/Q12 toolkit — Quality by Design, design space, control strategy, CPV and lifecycle management.

QbDDesign SpaceControl strategyPATICH Q9ICH Q10ICH Q11CPVPPQIQ / OQ / PQAPR / PQRChange ControlManagement Review
Talk to us about Tech Transfer

Want to see how Tech Transfer could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Where this term comes up
PharmaceuticalContract Manufacturing
Inside V5
  • → Score your compliance gap — then download the validation pack.
  • → Document control — one version in force, every change signed and explained.
  • → QMS — quality records next to the work they concern.
Regulatory anchors
  • ICH Q10 §3.2.3
  • WHO TRS 961 Annex 7
Related terms
  • → PPQ
  • → CPV
  • → VMP
  • → 21 CFR 210
  • → 21 CFR 211
  • → 21 CFR 212
  • → 21 CFR 58
  • → ICH Q7
  • → ICH Q9
  • → ICH Q10
  • → ICH Q2
  • → ICH Q6
  • → GxP
  • → QP Release
  • → Conditional Release
  • → Deviation
  • → OOS

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC